| |
| |
|
| Insider
Information: |
Sabba Stephen L |
| Relationship: |
Director |
| City: |
Syosset |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
65,926 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,493,073 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
65,926 |
|
|
| Total
Value |
$2,493,073 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -22.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-03-05 |
28,926 |
|
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2015-06-29 |
37,000 |
2014-12-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2008-08-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2008-08-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2010-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
20,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2010-11-19 |
4 |
D |
$9.12 |
$0 |
D/D |
(0) |
3,332 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,372 |
10,704 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-11-10 |
4 |
B |
$11.69 |
$11,690 |
D/D |
1,000 |
11,704 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2011-11-14 |
4 |
B |
$11.50 |
$11,500 |
D/D |
1,000 |
12,704 |
2.39 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,721 |
15,425 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2012-06-01 |
4 |
A |
$12.02 |
$24,040 |
D/D |
2,000 |
17,425 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2013-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,621 |
21,046 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-02-27 |
4 |
S |
$72.25 |
$36,125 |
D/D |
(500) |
20,546 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,151 |
21,697 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-10-09 |
4 |
A |
$43.12 |
$86,230 |
D/D |
2,000 |
23,697 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-10-09 |
4/A |
B |
$43.12 |
$86,230 |
D/D |
2,000 |
23,697 |
2.39 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-04-24 |
4/A |
A |
$0.00 |
$0 |
D/D |
925 |
26,622 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
12,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-29 |
4 |
OE |
$3.30 |
$87,125 |
D/D |
25,000 |
37,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
622 |
27,244 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
27,910 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-12-20 |
4 |
S |
$137.25 |
$126,956 |
D/D |
(925) |
26,985 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-03-12 |
4 |
S |
$180.73 |
$112,414 |
D/D |
(622) |
26,363 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
26,856 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-09-04 |
4 |
OE |
$8.58 |
$66,150 |
D/D |
5,000 |
31,856 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
